explore -WSS

explore

author：leisure time 2025-09-30 18:42:53 - browse：97711

This is the inaugural edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

Hello! Welcome to the premiere issue of Adam’s Biotech Scorecard. I’m excited to get started. Let’s do this! (By the way, the AF in the logo are my initials, not the “other” AF.)

The contrarian view of Viking Therapeutics

Closeup financial chart

The developer of a dual-acting GLP-1/GIP treatment for obesity is riding high on positive data and takeout speculation. The drug, called VK2735, has shown impressive weight loss with minimal gastrointestinal side effects in both subcutaneous and oral formulations, positioning it as a strong challenger to the obesity juggernauts from Eli Lilly and Novo Nordisk. With a stock price that has soared nearly 800% over the past year, Viking is now a $9 billion company and a prime acquisition target for a cash-rich pharma company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： EU fines Illumina $475 million over Grail acquisition

Wikipedia

WSS

Antibody drugs appear effective. Now can we make enough of them?

Venture capitalist Bob Kocher on the state of digital health

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Vermont grapples with historic flooding as more rainstorms head for Northeast

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Wearables generate powerful data but its not useful to doctors, yet

Wikipedia

explore

The contrarian view of Viking Therapeutics

Wikipedia

Duchenne breakthrough therapy leaves behind pioneering families

Inflation cooled significantly in June, bringing price hikes close to normal levels

Dobbs anniversary: the lost opportunity of abortion as health care

Glen Campbell's doctor discusses his public struggle with Alzheimer's

In age of alternative facts, a scholarly course on calling out crap

Digital health funding stays low as a new reality sets in

New air purifier tech could be key to improving indoor air quality

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Heart attack and stroke risk calculators need revising

It's time to retire 'poor historian' from clinicians' vocabularies

explore

Helping hospitals and community health centers plan for resilience

Grail's uphill battle for Medicare to cover its cancer screening test

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Readers respond to H5N1 and livestock movements, and more

Vermont grapples with historic flooding as more rainstorms head for Northeast

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Wikipedia

Wikipedia

explore

focus